National Policy on Traditional Medicine and Regulation of Herbal Medicines - Report of a WHO Global Survey
(2005; 168 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAcknowledgements
Ver el documentoExecutive summary
Ver el documentoAcronyms, abbreviations and definitions
Ver el documentoWHO Regions
Abrir esta carpeta y ver su contenido1. Introduction
Abrir esta carpeta y ver su contenido2. National policy on traditional medicine and complementary/alternative medicine
Cerrar esta carpeta3. The regulatory situation of herbal medicines
Ver el documento3.1 Law or regulation on herbal medicines
Ver el documento3.2 Regulatory status of herbal medicines
Ver el documento3.3 Claims
Ver el documento3.4 Pharmacopoeias
Ver el documento3.5 Monographs on herbal medicines
Ver el documento3.6 Manufacture of herbal medicines
Ver el documento3.7 Safety and herbal medicines
Ver el documento3.8 Registration system for herbal medicines
Ver el documento3.9 Herbal medicines and the essential drug list
Ver el documento3.10 Post marketing surveillance of herbal medicines
Ver el documento3.11 The sale of herbal medicines
Ver el documento3.12 Annual market sales of herbal medicines
Abrir esta carpeta y ver su contenido4. Member States, WHO and herbal medicines
Abrir esta carpeta y ver su contenido5. Country summaries
Ver el documentoReferences
Ver el documentoAnnex 1. Text of survey instrument
 

3.12 Annual market sales of herbal medicines

In the final question in this section related to the regulation of herbal medicines, countries were asked to provide data about annual market sales for herbal medicine for the most recent three years. The question also asked for clarification of the source of the figures provided.

Thirty countries provided some data on annual market sales of herbal medicines. However, as the data were largely fragmentary, the compiled results represent the nine Member States that included data for the period 1999-2001. It includes Member States from all six WHO Regions, with varying levels of economic development. The data which were excluded from the compilation were not complete, or were not provided for the chosen period. Finally, some countries provided figures in terms of packs of tablets or bottles of tonics, but such figures are not comparable between countries.

The nine States included in the results below (Figure 42) are Bhutan, Canada, Czech Republic, Islamic Republic of Iran, Madagascar, Malaysia, Pakistan, Sudan and Sweden. When figures were given in local currency, they were converted to United States dollars, using the exchange rates published by the United Nations on 1 November 2003.

The data excluded from the compilation above provide further evidence of the rise in annual market sales of herbal medicine globally.


Figure 42. Annual market sales of herbal medicines in nine countries, 1999-2001

 

Ir a la sección anterior
Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 29 agosto 2014